BioSpace News Archive

Pharm Country

Q BioMed announces publication of research showing augmented efficacy of its drug candidate Uttroside-B against liver cancer

Q BioMed, Inc. (OTCQB: QBIO) a commercial-stage biotechnology development company announces a new publication supporting the efficacy and further development of its Uttroside B chemotherapeutic to treat liver cancer.

March 16, 2022
·
5 min read
BioForest

Tend Announces Initiation of Clinical Study Evaluating the Comparability of CAP Device for the Delivery of FMT in Critically Ill Patients

Tend (“the company”), a microbiome solutions company, today announced the initiation of clinical studies for its Gut Microbiome Collect and Prep (CAP) device to prepare capsules for Fecal Microbiota Transplant (FMT) for patients with recurrent Clostridium difficile (C. diff) infections.

March 16, 2022
·
3 min read
Business

Moderna and the Japanese Government Reach an Agreement to Supply Japan with Additional 70 Million Doses of Moderna’s COVID-19 Booster Vaccine

Moderna, Inc. today announced an agreement with the Ministry of Health, Labour and Welfare of Japan (MHLW) to supply Japan with an additional 70 million doses of Moderna’s COVID-19 booster vaccine or an updated booster vaccine candidate, if authorized, for anticipated delivery in the second half of 2022.

March 16, 2022
·
3 min read
Business

Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Strengthens Senior Leadership Team with Key Appointments

“With novel compounds in two lead programs now in clinical development, this is an inflection point for Kallyope.

March 16, 2022
·
3 min read
OliX Pharmaceuticals Presents Potential Utility of GalNAc-asiRNA Platform at OPT Congress

OliX Pharmaceuticals, Inc. announced that Behfar Ardehali, Ph.D., Senior Scientist of the Company, presented at the 7th Annual OPT Congress Oligonucleotide & Precision Therapeutics.

March 16, 2022
·
1 min read
Genetown

Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference

Yield10 Bioscience, Inc. today announced that its Chief Executive Officer Dr. Oliver Peoples, Ph.D. will present at the Advanced Bioeconomy Leadership Conference 2022 (“ABLC”) being held at the Mayflower Hotel in Washington D.C. March 16-18, 2022.

March 16, 2022
·
6 min read
Business

Radius Health Announces Leadership Appointments

Radius Health, Inc., announced appointments to new roles on its executive leadership team, effective immediately.

March 16, 2022
·
2 min read
Business

Relmada Therapeutics to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 23, 2022

Relmada Therapeutics, Inc. today announced that it will report its financial results for the fourth quarter and full-year ended December 31, 2021 after the market close on Wednesday, March 23, 2022 .

March 16, 2022
·
3 min read
Business

Kieran P. Murphy, Former CEO of GE Healthcare, Joins Gamma Biosciences as Executive Chairman

Gamma Biosciences today announced that Kieran P. Murphy will join its Board of Directors as Executive Chairman.

March 16, 2022
·
3 min read
Pharm Country

Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics

Applied Therapeutics, Inc. today announced their abstract #OP005 was accepted as an oral platform presentation at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics, March 22 – 26, 2022 in Nashville, Tennessee.

March 16, 2022
·
4 min read